APG-115 induced apoptosis and the combination with ABT-199 exhibited a synergistic pro-apoptotic effect by further inhibiting the expression of BCL-2, BCL-xL, and MCL-1, suggesting a potential application in CLL therapy. Here, BCL2 is linked to B-cell chronic lymphocytic leukemia.